[1] NAPOLITANO I M. Immune stimulation in sepsis to be or not to be [J].Chest,2005,127(6):1882-1885.
[2] 纪国业,王斌,杜江,等.不同时间血液灌流对脓毒症兔血IL-6及TNFα的影响[J].现代医学,2011,39(2):129-133.
[3] DELLINGER R P,LEVY M M,RHODES A,et al.Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock,2012[J].Intensive Care Med,2013,39(2):165-228.
[4] ANNANC D,BCLLISSANT E,CAVAILLON J M.Septic shock[J].Lancet,2005,365(9453):63-78.
[5] 陈明祺,王醒.脓毒症患者免疫功能障碍研究进展[J].东南大学学报:医学版,2013,32(3):357-360.
[6] 宋振举,郦珊珊,童朝阳,等.脓毒症患者血清炎症/抗炎症细胞因子浓度与预后的相关性研究[J].中国急救医学,2008,28(9):785-787.
[7] SHAHKAR L,KESHTKAR A,MIRFAZELI A,et al.The Role of IL-6 for predicting neonatal sepsis:a systematic review and meta-analysis[J].Iran J Pediatr,2011,21(4):411-417.
[8] JEKARL D W,LEE S Y,LEE J,et al.Procalcitonin as a diagnostic marker and IL-6 as a prognostic marker for sepsis[J].Diagn Microbiol Infect Dis,2013,75(4):342-347.
[9] UUSITALO-SEPPÄLÄ R,KOSKINEN P,LEINO A,et al.Early detection of severe sepsis in the emergency room:diagnostic value of plasma C-reactive protein,procalcitonin,and interleukin-6[J].Scand J Infect Dis,2011,43(11-12):883-890.
[10] 沈丽娟,吴锡平,关云艳,等.脓毒症患者血清IL-6和NT-proBNP的变化及其临床意义[J].临床急诊杂志,2013,14(3):119-122.
[11] BOSKABADI H,MAAMOURI G,TAVAKOL AFSHARI J,et al.Evaluation of serum interleukins-6,8 and 10 levels as diagnostic markers of neonatal infection and possibility of mortality[J].Iran J Basic Med Sci,2013,16(12):1232-1237.
[12] 黄慧,傅应云,齐晖.IL-6、IL-18和TPO等指标对预测脓毒症预后的意义[J].中国医药指南,2013,11(23):544-545.
[13] RAJAN S,VYAS D,CLARK A T,et al.Intestine-specific over expression of IL-10 improves survival in polymicrobial sepsis[J].SHOCK,2008,29(4):483-489.
[14] CHUANG T Y,CHANG H T,CHUNG K P,et al.High levels of serum macrophage migration inhibitory factor and interleukin 10 are associated with a rapidly fatal outcome in patients with severe sepsis[J].Int J Infect Dis,2014,20:13-17.
[15] CHAUDHRY H,ZHOU J,ZHONG Y,et al.Role of cytokines as a double-edged sword in sepsis[J].In Vivo,2013,27(6):669-684. |